Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Zoledronic-Acid taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  
Zoledronic Acid Manufacturers in India Suppliers Zoledronic Acid Dossage Exporters Distributors Zoledronic Acid api active pharmaceuticals ingredients Zoledronic Acid manufacturers Side Effects bulk drugs raw material Dossage Zoledronic Acid companies Side Effects Dossage Importers Zoledronic Acid Dossage Zoledronic Acid Exporters Zoledronic Acid exporters Dossage FDA Dossage Zoledronic Acid Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd. active pharmaceutical ingredients suppliers pharmaceutical Zoledronic Acid manufacturing pharmaceutical drugs pharmaceutical intermediates Zoledronic Acid pharmaceutical chemicals pharmaceutical raw materials Zoledronic Acid active pharmaceutical ingredients Zoledronic Acid committee active pharmaceutical ingredients manufacturer Zoledronic Acid Active Pharmaceutical Ingredients manufacturer Zoledronic Acid exporter drug ingredients pharmaceuticals Pharmaceuticals API Manufacturer Zoledronic Acid, Zoledronic Acid manufacturer India, Zoledronic Acid product, Zoledronic Acid products, Api preparation, Certificate of Analysis API manufacturer product, Zoledronic Acid anti ulcer product, Certificate of Origin COA Zoledronic Acid COS Zoledronic Acid, pharmaceutical generic, pharmaceutical drug, medical, Zoledronic Acid pharma healthcare, pharma patents, contract MSDS manufacturing Trader Zoledronic Acid pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Zoledronic Acid expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Zoledronic Acid DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Zoledronic Acid ingredients, api, HIV Zoledronic Acid, tablets, capsules, syrup & protein Zoledronic Acid powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Zoledronic Acid gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Zoledronic Acid WHO, UKMHRA Approval
   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

api image pharmaceutical






 

 






 

 

HOME >> API >> API List 3 >> Zoledronic Acid >> Dosage

Zoledronic Acid CAS Registry Number 165800-06-6

DOSAGE
Zoledronic Acid
CAS Registry Number 165800-06-6

Follow all instructions for proper mixing and dilution with the correct IV fluids. Do not mix this drug with calcium-containing mixing solutions (e.g., Lactated Ringers). If you have questions regarding the use of this medication, consult your pharmacist. Give this medication by vein (IV) over at least 15 minutes in a saline (0.9% sodium chloride) or dextrose (D5W) solution as directed by your doctor. Additional IV fluids may be given before, during, or after your treatment with this drug. The dosage is based on your medical condition and response to therapy but should not be greater than 4 mg (each dose) or be given faster than the recommended rate (over 15 minutes). Doses greater than 4 mg or given quickly increase the risk for kidney problems. Consult your doctor or pharmacist. It may take up to 7 days before the full benefit of this drug takes effect. Before using, check this product visually for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard needles and medical supplies safely.

Zoledronic acid comes as a solution (liquid) to inject into a vein over at least 15 minutes. It is usually injected by a health care provider in a doctor's office, hospital, or clinic. When zoledronic acid injection is used to treat high blood levels of calcium caused by cancer it is usually given as a single dose. A second dose may be given at least 7 days after the first dose if blood calcium does not drop to normal levels or does not remain at normal levels. When zoledronic acid injection is used to treat bone damage caused by multiple myeloma or cancer that has spread to the bones, it is usually given once every 3-4 weeks. When zoledronic acid injection is used to treat osteoporosis, it is usually given once a year. When zoledronic acid is used to treat Paget's disease of bone, it is usually given as as a single dose, but additional doses may be given after some time has passed. You may experience a reaction during the first few days after you receive a dose of zoledronic acid injection. Symptoms of this reaction may include flu-like symptoms, fever, headache, and bone or muscle pain. These symptoms may begin during the first 3 days after you receive a dose of zoledronic acid injection and may last 3-14 days. Your doctor may recommend that you take a nonprescription pain reliever/fever reducer after you receive zoledronic acid injection to prevent or treat these symptoms.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE >>
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Zoledronic Acid

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap

 

taj group logo
© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.